
A medical device marketing consultant should prove they understand the product, the buyer, and how a deal closes before any campaign runs. Skip any of those, and the campaign is guessing.
Key Takeaways

A medical device marketing consultant has to know the product inside out before writing a single line of copy. Anything less shows up in the campaign as vague claims a competitor could paste onto their own device.
I interviewed Gene Nagel, who runs medical device sales training programs, on an episode about fixing medical sales training. Nagel named the sequence directly:
"You can bring in a consultant, which is what I would recommend, to really figure it out, because sometimes when you bring in a training person, here's what I found: training people typically are either a clinical technical person, they really understand the product, sometimes they're clinical engineers, but they don't have any sales experience, or you have more the classic sales trainer, and they don't have the other side of it.
So typically it's one or the other, and you need to be thinking about both, the clinical application, the technical aspects, and the sales piece.
And a consultant can help you with that, to get you that early framework."
Nagel's own timing is to bring that person in three to six months before launch, specifically to cover the gap a single training hire leaves open.
Nagel's point was that a training hire usually brings either the clinical and technical side or the sales side, and the company needs both covered.
A consultant who can't explain, unprompted, why the device works the way it does has nothing specific to say to a buyer. The campaign becomes a template with the company's name swapped in.

Product knowledge from a spec sheet differs from product knowledge learned in the room where the device gets used. A medical device marketing consultant who has never watched the procedure is working from secondhand information customers can spot.
Amanda Bloom, VP of Marketing at Radiaction, described the standard at NuVasive on an episode about medical device marketing:
"You need to know your customers, you need to be in those procedures. They will know if you're talking to them and you don't know what you're talking about. We were all very challenged, and that's where marketing and sales really were true partners."
That partnership only exists when marketing shows up in the field and not only in the CRM. Bloom's point was that customers know when a marketer has never seen the procedure.
A consultant who skips the field visit is optimizing for speed to campaign launch over accuracy. The campaign ships faster and lands flatter, because it was never tested against what the buyer sees and needs during the case.

The gap between a marketing consultant and a marketing partner shows up when you ask whether this person has ever ridden along with a sales rep on a live deal. Some medtech marketers never have.
I covered this in a guest appearance on the Medical Sales Accelerator podcast about what's wrong with medtech marketing, reading out a LinkedIn post I'd written:
"There are companies I've heard of where the marketers never went on a field ride with sales, which is unbelievable to me. And so they don't think about how do we own and contribute to revenue, how do we co-own deals with sales, how do we work collaboratively with them."
Without that exposure, a consultant treats a campaign as a content-production problem. Assets get made, a conference booth gets staffed, and leads get captured. None of that requires ever understanding how a specific deal moves from first contact to signature.
A consultant who has sat through a real sales cycle skips "what content do we need" and asks where in this deal a prospect gets stuck, and what closes that gap. That's the deliverable a campaign should be built around, instead of a content calendar.
Put those three pieces together, and a medical device marketing consultant's pre-campaign deliverable has a specific shape.
It's a written summary of the product's mechanism in plain language. A documented set of customer and procedure observations. A mapped version of how a deal moves from first contact to close.
None of that is campaign creative. It's the research a campaign gets built on top of, and skipping it is a fast way to produce a campaign that reads like every other medtech company's campaign.
A founder evaluating a consultant should ask to see this deliverable before approving any spend on ads, content, or a conference presence. If a consultant can't produce it, or treats the question as unnecessary, that's the screen failing before the campaign even starts.
A campaign built on that groundwork speaks to a specific buyer's specific moment of hesitation. One built without it produces generic assets that could belong to any device in the category.
The consultants worth hiring insist on this groundwork even when a founder is impatient to see creative.
That impatience is understandable. A founder watching runway burn wants to see ads and content instead of a research memo. But a campaign built without product fluency, field exposure, and a mapped sales process is spending that same runway on guesses.
The founders who get this right build the evaluation into the hiring process itself. They ask a prospective consultant to walk through how they'd spend the first month, and they expect to hear research and field time before creative.
A medical device marketing consultant who has done this work shows up to the first strategy meeting with specifics. The exact objection a surgeon raises. The exact moment a deal stalls. The exact language a buyer already uses.
That's medtech campaign readiness.
A consultant should learn the product in depth, observe the procedure directly, and map how a typical deal moves from first contact to close.
That means covering both the clinical and technical side and the sales side, since a single training hire usually only brings one.
Campaigns built without that groundwork tend to read generic. The consultant has no specific knowledge to draw from.
Gene Nagel recommends bringing in a consultant or a training manager about three to six months before commercial launch. That gives the consultant time to learn the product, observe procedures, and map the sales process before any campaign asset gets produced.
Starting that early also lets a founder review the product summary, procedure notes, and deal map before approving any spend.
Most feel generic because the person building them has never observed the procedure or ridden along on a real sales cycle. Customers can tell when someone has never seen the case.
Without that firsthand exposure, campaigns default to language any competitor could reuse. Nothing specific to the buyer's experience made it into the work.
If you're doing this yourself. Read the healthcare marketing agency taxonomy to see which type of partner is built for this kind of hands-on groundwork before you brief anyone on a campaign.
If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. For founders about to brief a consultant, the audit confirms the product, market, and sales groundwork is in place first.
Subscribe wherever you listen to podcasts.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.